EN
繁
简
About SSY Group
Company Profile
Chairman’s Statement
Directors and Senior Management
Corporate Video
Our Business
Major Products
Investor Relations
Announcements and Notices
Corporate Governance
Financial Reports
Presentations
Returns on Share Capital
Circulars
Shareholder Services
Corporate Information
News
Press Releases
Contact Us
IR and Media Contact
Announcements and Notices
Home
Investor Relations
Announcements and Notices
2021
Select Year
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Dec
28
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Dec
14
VOLUNTARY ANNOUNCEMENT - HYDROXYETHYL STARCH 130 AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
Dec
13
VOLUNTARY ANNOUNCEMENT - UPDATE ON POSSIBLE SPIN-OFF OF JIANGSU BEST NEW MEDICAL
Oct
20
UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021
Oct
18
VOLUNTARY ANNOUNCEMENT - POSSIBLE SPIN-OFF AND QUOTATION AND/OR LISTING ON A STOCK EXCHANGE IN MAINLAND CHINA
Oct
11
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
10
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Sep
03
VOLUNTARY ANNOUNCEMENT - UPDATE ON BUSINESS DEVELOPMENT
Aug
27
List of Directors and their Role and Function
Aug
27
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS
Aug
27
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
Aug
25
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Aug
17
DATE OF BOARD MEETING
Jul
29
DISCLOSEABLE TRANSACTION - ACQUISITION OF LISTED SECURITIES
Jul
28
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jul
23
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jul
06
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jul
02
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jun
30
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Jun
24
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
May
27
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
May
21
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING
May
21
POLL RESULTS OF ANNUAL GENERAL MEETING 2021
May
03
NOTICE OF EXTRAORDINARY GENERAL MEETING
Apr
30
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021
Apr
19
Notice of Annual General Meeting
Apr
14
CONTINUING CONNECTED TRANSACTIONS - MASTER SALE AND PURCHASE AGREEMENT
Apr
12
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Mar
30
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
Mar
25
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Mar
18
DATE OF BOARD MEETING
Mar
12
VOLUNTARY ANNOUNCEMENT - METRONIDAZOLE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
Mar
01
CHANGE OF ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS
Feb
26
PROFIT WARNING
Feb
03
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
Jan
21
VOLUNTARY ANNOUNCEMENT - FLUCONAZOLE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
Jan
13
VOLUNTARY ANNOUNCEMENT - CIPROFLOXACIN LACTATE AND SODIUM CHLORIDE INJECTION PASSED CONSISTENCY EVALUATION
Jan
12
GRANT OF SHARE OPTIONS